Home > Publications database > Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. > print |
001 | 291690 | ||
005 | 20250123112130.0 | ||
024 | 7 | _ | |a 10.18632/oncotarget.28527 |2 doi |
024 | 7 | _ | |a pmid:39018218 |2 pmid |
037 | _ | _ | |a DKFZ-2024-01494 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Zhang, Yiyao |0 P:(DE-HGF)0 |b 0 |e First author |
245 | _ | _ | |a Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer. |
260 | _ | _ | |a [Erscheinungsort nicht ermittelbar] |c 2024 |b Impact Journals LLC |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1737627653_4292 |2 PUB:(DE-HGF) |x Erratum/Correction |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a Original article: Oncotarget. 2015; 6:9999–10015. https://doi.org/10.18632/oncotarget.3171 |
536 | _ | _ | |a 319H - Addenda (POF4-319H) |0 G:(DE-HGF)POF4-319H |c POF4-319H |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a Gemcitabine |2 NLM Chemicals |
650 | _ | 7 | |a Deoxycytidine |0 0W860991D6 |2 NLM Chemicals |
650 | _ | 7 | |a Aspirin |0 R16CO5Y76E |2 NLM Chemicals |
650 | _ | 7 | |a Antimetabolites, Antineoplastic |2 NLM Chemicals |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a Gemcitabine |2 MeSH |
650 | _ | 2 | |a Deoxycytidine: analogs & derivatives |2 MeSH |
650 | _ | 2 | |a Deoxycytidine: pharmacology |2 MeSH |
650 | _ | 2 | |a Deoxycytidine: therapeutic use |2 MeSH |
650 | _ | 2 | |a Pancreatic Neoplasms: drug therapy |2 MeSH |
650 | _ | 2 | |a Pancreatic Neoplasms: pathology |2 MeSH |
650 | _ | 2 | |a Pancreatic Neoplasms: metabolism |2 MeSH |
650 | _ | 2 | |a Drug Resistance, Neoplasm: drug effects |2 MeSH |
650 | _ | 2 | |a Aspirin: pharmacology |2 MeSH |
650 | _ | 2 | |a Aspirin: therapeutic use |2 MeSH |
650 | _ | 2 | |a Neoplastic Stem Cells: drug effects |2 MeSH |
650 | _ | 2 | |a Neoplastic Stem Cells: pathology |2 MeSH |
650 | _ | 2 | |a Neoplastic Stem Cells: metabolism |2 MeSH |
650 | _ | 2 | |a Antimetabolites, Antineoplastic: pharmacology |2 MeSH |
700 | 1 | _ | |a Liu, Lizhen |0 P:(DE-He78)0144e4bf6eab6053de5a445069012063 |b 1 |
700 | 1 | _ | |a Fan, Pei |0 P:(DE-HGF)0 |b 2 |
700 | 1 | _ | |a Bauer, Nathalie |0 P:(DE-He78)bf58bfc5eb550025e7f1f64520b68feb |b 3 |
700 | 1 | _ | |a Gladkich, Jury |0 P:(DE-HGF)0 |b 4 |
700 | 1 | _ | |a Ryschich, Eduard |b 5 |
700 | 1 | _ | |a Bazhin, Alexandr V |b 6 |
700 | 1 | _ | |a Giese, Nathalia A |b 7 |
700 | 1 | _ | |a Strobel, Oliver |b 8 |
700 | 1 | _ | |a Hackert, Thilo |b 9 |
700 | 1 | _ | |a Hinz, Ulf |b 10 |
700 | 1 | _ | |a Gross, Matthias Wolfgang |0 P:(DE-He78)d39b542b3a0da04c8892923daf9e5794 |b 11 |
700 | 1 | _ | |a Fortunato, Franco |b 12 |
700 | 1 | _ | |a Herr, Ingrid |0 P:(DE-HGF)0 |b 13 |e Last author |
773 | _ | _ | |a 10.18632/oncotarget.28527 |g Vol. 15, no. 1, p. 504 - 506 |0 PERI:(DE-600)2560162-3 |n 1 |p 504 - 506 |t OncoTarget |v 15 |y 2024 |x 1949-2553 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:291690 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)0144e4bf6eab6053de5a445069012063 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)bf58bfc5eb550025e7f1f64520b68feb |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-HGF)0 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)d39b542b3a0da04c8892923daf9e5794 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-HGF)0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-319H |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Addenda |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-29 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-08-29 |
920 | 2 | _ | |0 I:(DE-He78)G403-20160331 |k G403 |l Molekulare Onkochirurgie |x 0 |
920 | 1 | _ | |0 I:(DE-He78)G403-20160331 |k G403 |l Molekulare Onkochirurgie |x 0 |
920 | 0 | _ | |0 I:(DE-He78)G403-20160331 |k G403 |l Molekulare Onkochirurgie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)G403-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|